Le Lézard
Classified in: Health

RTOERO urges collective action towards sustainable, just future at federal advocacy event

Toronto, April 26, 2023 (GLOBE NEWSWIRE) -- RTOERO volunteers and staff met with federal MPs and government officials during its second Advocacy on the Hill event on April 24 and 25. During virtual meetings both days and an in-person reception on April 25, RTOERO Board of Directors, Political Advocacy Committee members and senior staff dialogued with MPs and government staff about RTOERO's key advocacy issues:

"The pandemic magnified the pre-existing fractures in our social service structure?for older adults and other vulnerable groups," says Martha Foster, chair of RTOERO's Board of Directors. "We have an opportunity now to work together and rebuild the system collaboratively?we can't squander this chance."

RTOERO white papers on its key issues were shared with MPs and staff covering various ministries. RTOERO offered its expertise and insight to help improve the lives of seniors in Canada. The RTOERO team urged officials and MPs to take collective action toward a more sustainable and just future for all Canadians.

Notes Foster, "RTOERO members, and many Canadians, want and expect change, and we want to be part of it. The question is, collectively, what legacy do we want to leave? What really matters?"

In addition to advocacy, RTOERO focuses several initiatives on these key priority areas, including:



RTOERO is a bilingual trusted voice on healthy, active living in the retirement journey for the broader education community. With 83,000+ members in 51 districts across Canada, we are the largest national provider of non-profit group health benefits for education retirees. We welcome members who work in or are retired from the early years, schools and school boards, post-secondary and any other capacity in education. We believe in a better future, together!


These press releases may also interest you

at 19:30
Everest Medicines' (HKEX 1952.HK, "Everest", or the "Company") partner Calliditas Therapeutics AB ("Calliditas") presented new biomarker and subgroup analyses from Nefecon®'s Phase 3 NefIgArd study in both posters and oral presentations at the 17th...

at 19:19
Community Healthcare Trust Incorporated  today announced that on Tuesday evening, October 31, 2023, after the market closes, it will report results for the third quarter of 2023.  On November 1, 2023, at 9:00 a.m. Central Time, Community Healthcare...

at 18:45
The "Vulvovaginal Candidiasis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Drug Class, By Route of Administration, By Distribution Channel, By Region and Competition" report has been added...

at 18:00
With the Alignment for Progress Conference at a close, The Kennedy Forum has officially launched the Alignment for Progress Movement. On the first day of the Conference, The Kennedy Forum set forth three audacious goals: By 2033 90% of all...

at 17:35
Puma Biotechnology, Inc. , a biopharmaceutical company, announced that on October 2, 2023, the Compensation Committee of Puma's Board of Directors approved the grant of an inducement restricted stock unit award covering 7,500 shares of Puma common...

at 17:25
The International Society for Pharmaceutical Engineering (ISPE) is excited to announce that Robert M. Califf, MD, Commissioner of Food and Drugs at the United States Food and Drug Administration (FDA), will be featured in a keynote session at the...

News published on and distributed by: